Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
The Journal of antimicrobial chemotherapy (2020) - Comments
doi: 10.1093/jac/dkaa334  issn: 0305-7453  issn: 1460-2091  pubmed: 32812039 

Anahita Sadeghi, Ali Ali Asgari, Alireza Norouzi, Zahedin Kheiri, Amir Anushirvani, Mahnaz Montazeri, Hadiseh Hosamirudsai, Shirin Afhami, Elham Akbarpour, Rasoul Aliannejad, Amir Reza Radmard, Amir H Davarpanah, Jacob Levi, Hannah Wentzel, Ambar Qavi, Anna Garratt, Bryony Simmons, Andrew Hill, Shahin Merat